e-learning
resources
Munich 2014
Sunday, 07.09.2014
The assessment of comorbidities
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Effect of oral corticosteroids on symptomatic reflux in severe allergic asthma: Is there a link?
R. Aziz, D. Saralaya, K. Regan, L. Walker (Bradford, United Kingdom)
Source:
International Congress 2014 – The assessment of comorbidities
Session:
The assessment of comorbidities
Session type:
Thematic Poster Session
Number:
973
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R. Aziz, D. Saralaya, K. Regan, L. Walker (Bradford, United Kingdom). Effect of oral corticosteroids on symptomatic reflux in severe allergic asthma: Is there a link?. Eur Respir J 2014; 44: Suppl. 58, 973
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Importance of concomitant local and systemic eosinophilia in uncontrolled asthma
Source: International Congress 2014 – Biomarkers of asthma control
Year: 2014
Discordance between asthma control parameters in patients with frequent vs infrequent asthma exacerbations
Source: International Congress 2014 – Non inflammatory monitoring of airway diseases
Year: 2014
Clinical effectiveness of anti-IgE therapy in severe asthma with fungus sensitization
Source: International Congress 2014 – Non inflammatory monitoring of airway diseases
Year: 2014
The course and outcomes of pregnancy in women with bronchial asthma
Source: International Congress 2014 – Clinical assessment of airway diseases
Year: 2014
Experience with omalizumab in patients with moderate and severe asthma
Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments
Year: 2014
Clinical effectiveness of anti-IgE therapy in allergic severe asthma
Source: International Congress 2014 – Asthma and COPD management
Year: 2014
The usefulness of FeNO and the mannitol test in detecting airway eosinophilia in asthma patients with uncontrolled symptoms
Source: International Congress 2014 – Biomarkers of asthma control
Year: 2014
Biomarkers for sputum eosinophilia in mild-moderate and severe adult-onset asthma patients
Source: International Congress 2014 – Systemic and airway biomarkers
Year: 2014
Role of gastro-oesophageal reflux in severe asthma: Experience from the Wessex severe asthma cohort
Source: International Congress 2015 – Clinical assessment in asthma and COPD
Year: 2015
Characteristics of the adult corticosteroid-dependent severe asthma in UBIOPRED consortium
Source: International Congress 2014 – Novel targets and drugs for asthma and COPD
Year: 2014
Factors associated with uncontrolled asthma in patients with aspirin-exacerbated respiratory disease (AERD)
Source: International Congress 2014 – Asthma: still a heterogeneous condition!
Year: 2014
Dysphonia in asthmatic women using inhaled corticosteroids: It is not only a laryngeal inflammation
Source: International Congress 2016 – Novel mechanisms and treatment modalities in asthma
Year: 2016
Evaluation of methotrexate in the treatment of severe asthma
Source: International Congress 2015 – Novel treatments for cough, asthma, COPD and bronchiectasis
Year: 2015
Influence of psychological characteristics of patients for asthma control
Source: International Congress 2014 – The assessment of comorbidities
Year: 2014
Factors associated with irreversible airway obstruction in patients with asthma
Source: International Congress 2014 – Asthma or COPD: comorbid condition or a poorly understood single disease?
Year: 2014
Monitoring of airway resistance (Raw) in exacerbation of asthma
Source: Annual Congress 2013 –Monitoring lung function in airway diseases
Year: 2013
Efficacy of carbamazepine in treatment of bronchial asthma
Source: Annual Congress 2013 –Asthma and COPD management: novel clinical findings
Year: 2013
Effects of beta-blockers on lung function in bronchial asthma patients
Source: International Congress 2014 – Asthma or COPD: comorbid condition or a poorly understood single disease?
Year: 2014
Assessing asthma risk in primary care: Can the AAA test predict future asthma attacks?
Source: International Congress 2014 – Biomarkers of asthma control
Year: 2014
Implication of IL-18 in the chronic inflammation of severe refractory asthma
Source: International Congress 2014 – Systemic and airway biomarkers
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept